Gabriel Leung, Director at NovoCure Ltd (NVCR), sold 19,077 shares at $67.46 ($1.3M) on 2020-07-22, disclosed to the SEC on 2020-07-23.
Open-market sale of $1.3M NVCR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.07 | 500 | $33K | 2.5% |
| 2 | $65.48 | 423 | $28K | 2.2% |
| 3 | $66.75 | 4,573 | $305K | 23.9% |
| 4 | $66.75 | 4,573 | $305K | 23.9% |
| 5 | $67.46 | 4,504 | $304K | 23.8% |
| 6 | $67.46 | 4,504 |
| $304K |
| 23.8% |
| Total | $67.01 avg | 19,077 | $1.3M | 100% |
| Filing → |
| NVCR | SELL | 2024-06-06 | $23K | — | Filing → |
| NVCR | SELL | 2021-08-06 | $153K | — | Filing → |
| NVCR | SELL | 2021-07-08 | $184K | — | Filing → |